Federal Act
on Controlling Communicable Human Diseases
(Epidemics Act, EpidA)


Open article in different language:  DE  |  FR  |  IT
Art. 44 Supply of therapeutic products

1 The Fed­er­al Coun­cil shall en­sure that the pop­u­la­tion is sup­plied with the most im­port­ant thera­peut­ic products that are suit­able for con­trolling com­mu­nic­able dis­eases, in­so­far as it is un­able to guar­an­tee sup­ply by means of meas­ures un­der the Na­tion­al Eco­nom­ic Sup­ply Act of 8 Oc­to­ber 19827.

2 It may is­sue reg­u­la­tions on:

a.
al­loc­at­ing thera­peut­ic products;
b.
dis­trib­ut­ing thera­peut­ic products;
c.
fa­cil­it­at­ing the im­port and re­strict­ing or pro­hib­it­ing the ex­port of thera­peut­ic products, provided this is ne­ces­sary in or­der to avert a pub­lic health risk;
d.
main­tain­ing stocks of thera­peut­ic products in hos­pit­als and oth­er health­care in­sti­tu­tions.

3 It may provide for meas­ures to sup­ply Swiss cit­izens liv­ing abroad with thera­peut­ic products.

7 [AS 1983 931; 1992 288An­nex No 24; 1995 1018, 1794; 1996 3371An­nex 2 No 1; 2001 1439; 2006 2197An­nex No 48; 2010 1881An­nex 1 No II 18; 2012 3655No I 15. AS 2017 3097An­nex 2 No I]. See now: the Na­tion­al Eco­nom­ic Sup­ply Act of 17 June 2016 (SR 531).

Diese Seite ist durch reCAPTCHA geschützt und die Google Datenschutzrichtlinie und Nutzungsbedingungen gelten.

Feedback
Laden